mlsanityData to 14 Oct 2026

TJDR: A High-Quality Diabetic Retinopathy Pixel-Level Annotation Dataset

arXiv 2312.15389 ↗First posted 24 Dec 2023eess.IV cs.CVcited by 3

Not on the map. Why?

Abstract (arXiv)

Diabetic retinopathy (DR), as a debilitating ocular complication, necessitates prompt intervention and treatment. Despite the effectiveness of artificial intelligence in aiding DR grading, the progression of research toward enhancing the interpretability of DR grading through precise lesion segmentation faces a severe hindrance due to the scarcity of pixel-level annotated DR datasets. To mitigate this, this paper presents and delineates TJDR, a high-quality DR pixel-level annotation dataset, which comprises 561 color fundus images sourced from the Tongji Hospital Affiliated to Tongji University. These images are captured using diverse fundus cameras including Topcon's TRC-50DX and Zeiss CLARUS 500, exhibit high resolution. For the sake of adhering strictly to principles of data privacy, the private information of images is meticulously removed while ensuring clarity in displaying anatomical structures such as the optic disc, retinal blood vessels, and macular fovea. The DR lesions are annotated using the Labelme tool, encompassing four prevalent DR lesions: Hard Exudates (EX), Hemorrhages (HE), Microaneurysms (MA), and Soft Exudates (SE), labeled respectively from 1 to 4, with 0 representing the background. Significantly, experienced ophthalmologists conduct the annotation work with rigorous quality assurance, culminating in the construction of this dataset. This dataset has been partitioned into training and testing sets and publicly released to contribute to advancements in the DR lesion segmentation research community.

Key facts. Cited by 3 papers in the map (data through 14 Oct 2026). Builds on 0 of its 2 references that are in the map. First posted on arXiv 24 Dec 2023.

Builds on

0 of 2 references.

No references here yet.

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2024: 1; 2025: 1; 2026: 1.

3 papers.